CPT 81460: Mitochondrial Genome Sequencing Panel
Commercial payers pay $1323 on average nationally for this procedure.
CPT code 81460 describes a genomic sequencing panel that analyzes the entire mitochondrial genome from a patient specimen to detect pathogenic variants and assess heteroplasmy levels related to neuromuscular or mitochondrial disorders; service type is molecular genetic diagnostic testing (mitochondrial genome sequence analysis) typically performed in an clinical molecular genetics laboratory or reference diagnostic laboratory with testing carried out on blood, tissue, or other appropriate clinical specimens.
Customize your policy alerts
Sign up for cpt 81460 policy alerts
Get alerted when payer policies referencing 81460 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial rates for CPT 81460 cluster around the BUCA average commercial rate of $1,323.40, with individual payers showing meaningful variation. Blue Cross Blue Shield has the highest spread in central tendency (P75–P25 = $489.30), suggesting wider negotiated outcomes, while Cigna and UnitedHealth Group show intermediate dispersion at $1,042.00 and $731.50 respectively. Aetna’s distribution is relatively tight with a P75–P25 of $713.00.
Overall dispersion highlights that Blue Cross Blue Shield delivers the widest interquartile range, signaling more heterogeneity in contracted rates, whereas Aetna is among the tighter payers. UnitedHealth Group’s lower median relative to its mean indicates skew toward higher outliers, and Cigna’s larger P75–P25 reflects broader variability around its median of $1,153.20.